Race versus place of service in mortality among medicare beneficiaries with cancer

Cancer

Volumn 116, Issue 11, 2010, Pages 2698-2706

  Onega, Tracy ^a,b,c   Duell, Eric J ^a,b,c,d   Shi, Xun ^e   Demidenko, Eugene ^b,c   Goodman, David C ^a,b  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e Dartmouth College   (United States)

Author keywords

Health facilities; Healthcare disparities; Mortality; Quality of healthcare

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER MORTALITY; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; INCIDENTAL FINDING; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RISK ASSESSMENT;

EID: 77952800765     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25097     Document Type: Article

References (50)

1. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2002.
2. Escarce JJ. Racial and Ethnic Disparities in Access to and Quality of Health Care. Research Synthesis Report No. 12 (September). Princeton, NJ: Robert Wood Johnson Foundation; 2007.
3. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113. (Pubitemid 34437345)
4. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst. 2001;93:501-515. (Pubitemid 32318429)
5. Baicker K, Chandra A, Skinner JS, Wennberg JE. Who you are and where you live: how race and geography affect the treatment of Medicare beneficiaries [serial online]. Health Aff (Millwood). 2004;suppl web exclusives:VAR33-VAR44.
6. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med. 2005;353:692-700. (Pubitemid 41175677)
7. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Relationship between quality of care and racial disparities in Medicare health plans. JAMA. 2006;296:1998-2004. (Pubitemid 44631446)
8. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. SEER website. Available at: http://seer.cancer.gov/about/. Accessed July 24, 2009.
9. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. SEER Cancer Statistics Review, 1975-2002. Bethesda, Md: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2002/results-merged/ topic-age-dist.pdf. Accessed July 24, 2009.
10. Onega TDE, Shi X, Demidenko E, Goodman D. Determinants of NCI cancer center attendance among Medicare beneficiaries with lung, breast, colorectal, or prostate cancer. J Gen Intern Med. 2008;24:205-210.
11. Schrag D, Bach PB, Dahlman C, Warren JL. Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources. Med Care. 2002; 40(8 suppl):IV-96-IV-103.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373-383. (Pubitemid 17055592)
13. Iezzoni LI, Foley SM, Daley J, Hughes J, Fisher ES, Heeren T. Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA. 1992;267:2197-2203.
14. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258-1267.
15. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002;40(8 suppl): IV-26-IV-35.
16. Onega T, Duell EJ, Shi X, Wang D, Demidenko E, Goodman D. Geographic access to cancer care in the United States. Cancer. 2008;112:909-918. (Pubitemid 351240585)
17. Onega T, Duell EJ, Goodman DC, Demidenko E, Shi X. Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients. Med Care Res Rev. 2009;66:542-560.
18. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162:1985-1993.
19. Dignam JJ. The ongoing search for the sources of the breast cancer survival disparity. J Clin Oncol. 2006;24:1326-1328.
20. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272:947-954.
21. Farkas A, Marcella S, Rhoads GG. Ethnic and racial differences in prostate cancer incidence and mortality. Ethn Dis. 2000;10:69-75.
22. Godley PA, Schenck AP, Amamoo MA, et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst. 2003; 95:1702-1710. (Pubitemid 37509079)
23. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
24. Marcella S, Miller JE. Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol. 2001;54:359-366. (Pubitemid 32303459)
25. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407-1427.
26. Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000;90:1746-1754.
27. Roetzheim RG, Pal N, van Durme DJ, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol. 2000;43(2 pt 1):211-218. (Pubitemid 30625995)
28. Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol. 2002;20:3999-4005.
29. Onega T Duell EJ, Shi X, Demidenko E, Gottlieb D, Goodman DC. The influence of NCI cancer center attendance on mortality for lung, breast, colorectal, and prostate cancer patients. J Clin Oncol. 2009;66:5442-5560
30. Demissie K, Oluwole OO, Balasubramanian BA, Osinubi OO, August D, Rhoads GG. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between whites and blacks. Ann Epidemiol. 2004;14:215-221. (Pubitemid 38249336)
31. Ellison GL, Warren JL, Knopf KB, Brown ML. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res. 2003;38(6 pt 2):1885-1903.
32. Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008;112:900-908.
33. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006;24:2179-2187.
34. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002; 20:1192-1202.
35. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293-1300.
36. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93:850-857. (Pubitemid 32590779)
37. Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from Surveillance, Epidemiology, and End results-Medicare. J Clin Oncol. 2001;19:3712-3718. (Pubitemid 32844782)
38. Baldwin LM, Taplin SH, Friedman H, Moe R. Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma? Cancer. 2004;100:701-709.
39. Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998;82:2312-2320. (Pubitemid 28283436)
40. Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marrogi AJ. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:25-31.
41. Taylor AJ, Meyer GS, Morse RW, Pearson CE. Can characteristics of a health care system mitigate ethnic bias in access to cardiovascular procedures? Experience from the Military Health Services System. J Am Coll Cardiol. 1997;30:901-907.
42. Barnato AE, Lucas FL, Staiger D, Wennberg DE, Chandra A. Hospital-level racial disparities in acute myocardial infarction treatment and outcomes. Med Care. 2005;43:308-319. (Pubitemid 40515620)
43. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care. 2005;43:320-329.
44. Skinner J, Chandra A, Staiger D, Lee J, McClellan M. Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients. Circulation. 2005;112: 2634-2641. (Pubitemid 41532600)
45. Birkmeyer NJ, Goodney PP, Stukel TA, Hillner BE, Birkmeyer JD. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer. 2005;103:435-441.
46. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134-147.
47. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer. 2003; 97:2853-2860.
48. Maggard MA, Thompson JE, Ko CY. Why do breast cancer mortality rates vary across states? Am Surg. 2003;69:59-62.
49. Morris AM, Billingsley KG, Baxter NN, Baldwin LM. Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg.2994l139:151- 155; discussion 156.
50. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198-1205. (Pubitemid 29480659)